Given that these changes result explicitly from the expression and phosphorylation of PAX3-FOXO1, we conclude that the acquisition of the oncogene is the initiating driver mutation in the development of ARMS. The gene discussed is FOXO1; the disease is alveolar rhabdomyosarcoma.